LEUKEMIA INHIBITORY FACTOR OR RELATED FACTORS PROMOTE THE DIFFERENTIATION OF NEURONAL AND ASTROCYTIC PRECURSORS WITHIN THE DEVELOPING MURINE SPINAL-CORD
Lj. Richards et al., LEUKEMIA INHIBITORY FACTOR OR RELATED FACTORS PROMOTE THE DIFFERENTIATION OF NEURONAL AND ASTROCYTIC PRECURSORS WITHIN THE DEVELOPING MURINE SPINAL-CORD, European journal of neuroscience, 8(2), 1996, pp. 291-299
Previously we have shown that leukaemia inhibitory factor (LIF) potent
iates the development of murine spinal cord neurons in vitro, suggesti
ng that it, or related factors, may play an important regulatory role
in neuronal development. We have further investigated this role and sh
ow here that the generation of neurons in cultures of embryonic day In
spinal cord cells is inhibited by antibodies to the beta subunit of t
he LIF receptor. Since there are more undifferentiated precursors in a
ntibody-treated cultures than in control and LIF-treated cultures, it
is concluded that the primary action of LIF, or related molecules, is
to promote neuronal differentiation, not precursor survival, In additi
on, the failure of LIF to support neuronal survival in the period imme
diately following differentiation suggests that the increased numbers
of neurons generated with LIF are not attributable to its neurotrophic
action. By selecting neuronal precursors on the basis of their inabil
ity to express class I major histocompatibility complex molecules, it
was shown that LIF acted directly upon these cells and not via an inte
rmediary cell. LIF also appears to be involved in regulating the diffe
rentiation of astrocytes, since it increases the number of glial fibri
llary protein (GFAP)-positive cells present in the cultures and since
the spontaneous production of GFAP-positive cells is blocked by antibo
dies to the LIF beta receptor. These findings suggest that LIF or rela
ted factors promote the differentiation of neural precursors in the sp
inal cord, but that they. are not involved in preferentially promoting
precursors down a specific differentiation pathway.